AzTrials
AzTrials

Traumatic Brain InjuryNCT01908647

Using Real-Time Functional Brain Imaging to Enhance Recovery From TBI

A study testing RT fMRI and Cognitive Training in people with Traumatic Brain Injury and Post Traumatic Stress Disorder, run by Van Boven, Robert W., M.D. at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this randomized, controlled clinical trial, we will evaluate the effects of (1) a brain-training program that uses real-time neurofeedback in functional magnetic resonance imaging (fMRI) to allow people to learn how to gain voluntary control over activity in targeted brain regions and/or (2) 8 weeks of… Read more about this study

Who is it for?
Ages 18 to 45 years
What is being tested?
RT fMRI and Cognitive Training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
150 participants
Where
1 siteUnited States
Study dates
Apr 2014to Jul 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Mild TBI: PTA/confusion≤1 hour immediately after injury; or LOC <30 min [69] confirmed by the Ohio confirmed by the Ohio State University TBI Identification Method-Short Form (OSU TBI-ID-SF).
  • Age 18-45 years
  • Right handed [70].
  • Minimum of 4 months and within 36 months post-injury
  • Can participate in fMRI and outcome assessment
  • Adequate visual, auditory, sensory-motor function for training program.
  • Fluent in English
  • Persistent cognitive dysfunction confirmed by an objective measure

Who cannot join

  • History of hypoxic event
  • Pre-existing significant neurological (e.g. MS) or psychiatric (e.g. schizophrenia, bi-polar) disorders.
  • Current illicit drug use or ETOH abuse
  • Contraindications to MRI (metal, pregnant, pacemaker, claustrophobia, etc.).
  • Unwilling or unable (e.g. language barrier) to participate
  • Hospitalization during study
Show all 11Show fewer
  • Current Med Board for discharge, Litigation/ + malingering test [71]
  • Use of medications to enhance cognitive function (e.g. Ritalin)
  • Initial Glascow Coma Score <13 or penetrating head injury
  • Subjects must not show suicidal ideation as measured by the Columbia-Suicide Severity Rating Scale (C-SSRS; 111). Subjects with a score of 4 or 5 (as recommended by the FDA for treatment trials) will be excluded and referred for appropriate treatment.
  • Subjects should not be enrolled in a concurrent TBI clinical trial.

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • Carl R Darnall Army Medical Center (CRDAMC)

    Fort Hood, Texas, 76544

    Robert Van Boven, M.D., 847-477-9317, robert.vanboven@gmail.com

    Michel-Alexis Courines, M.D., 254-288-8309, michel.a.courtines.mil@mail.mil

    Recruiting

Other trials in United States

About this study

In this randomized, controlled clinical trial, we will evaluate the effects of (1) a brain-training program that uses real-time neurofeedback in functional magnetic resonance imaging (fMRI) to allow people to learn how to gain voluntary control over activity in targeted brain regions and/or (2) 8 weeks of computer-based cognitive training using a software program (Cognitive Remediation for Brain Injury (CRBI)) versus control training tasks on cognitive learning and symptoms. In addition, the investigators will measure brain function (active and resting functional magnetic resonance imaging) and structure (high resolution magnetic resonance imaging) before and after treatment.

Being tested
RT fMRI, Cognitive Training, Control RT fMRI, Control Cognitive Training
Keywords
mTBI, PTSD
Medical subject headings
Brain Injuries, Traumatic, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RT fMRIBehavioural

    Also called Real-time fMRI

    Real-time fMRI with neurofeedback.

  • Cognitive TrainingBehavioural

    Computer based attention training.

  • Control RT fMRIBehavioural

    Control condition for real-time fMRI.

  • Control Cognitive TrainingBehavioural

    Computer-based games used as a control for the computer based cognitive training intervention.

Study groups in NCT01908647
Study groupRoleWhat they receive
Exp RT fMRI/Exp Cognitive TrainingExperimentalBoth experimental conditions.
Receives: Behavioral: RT fMRI; Behavioral: Cognitive Training
Exp RT fMRI/Ctrl Cognitive trainingExperimentalExperimental real-time fMRI and control cognitive training.
Receives: Behavioral: RT fMRI; Behavioral: Control Cognitive Training
Ctrl RT fMRI/Exp Cognitive TrainingExperimentalControl RT fMRI (real-time functional MRI) and experimental cognitive training.
Receives: Behavioral: Cognitive Training; Behavioral: Control RT fMRI
Ctr RT fMRI/Ctr Cognitive TrainingSham comparatorControl real-time fMRI and control cognitive training.
Receives: Behavioral: Control RT fMRI; Behavioral: Control Cognitive Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neuropsychological assessments

    A composite score based on four primary domains (learning, memory, working memory and executive function).

    Measured: 8 weeks

Secondary outcomes (4)
  1. Participant-reported outcomes

    A measure of the impact of program use on the participants' own view of their impairment and function

    Measured: 8 weeks

  2. Working/School Status

    A measure of participants' employment status, schooling status, and the number of hours worked/volunteered/in school per week

    Measured: 8 weeks

  3. Exercise Based Assessments

    Three sets of assessments that are closely modeled on study-related exercises in the auditory, visual, and cognitive control modules, and include auditory speed of processing, visual speed of processing, and cognitive control speed of processing.

    Measured: 4 and 8 weeks

  4. Functional Assessments

    Two types of functional measures: a sensitive directly observed performance measure designed originally for normal cognitive aging (timed instrumental activities of daily living, TIADL), and a well-accepted clinical impression measure (the Mayo-Portland Adaptability Inventory, MPAI-4).

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2013 (estimated)
  2. Study startApr 2014
  3. Primary completionJul 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01908647
Sponsor's protocol ID
W81XWH-11-2-0180
Status last verified
Apr 2014
First submitted
22 Jul 2013
Last updated
28 Apr 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing RT fMRI and Cognitive Training in people with Traumatic Brain Injury and Post Traumatic Stress Disorder, run by Van Boven, Robert W., M.D. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 28 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kaela Miller (737-346-7017, kmiller@genevausa.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neuropsychological assessments (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in